NEW YORK: Brunswick Group took the top spot in terms of value on the mergermarket League Tables of PR Advisers for Q1-Q3 2009 for what the organization called the worst nine-month period in six years.
Buoyed by its role in the two largest deals of the year – Pfizer's bid for Wyeth and Roche Holdings bid for a stake in Genentech – Brunswick came in at number one for value with 75 deals worth $203.9 billion for the first three quarters. The firm represented Pfizer and Roche in those deals.
Rounding out the top three were Sard Verbinnen & Co. with 47 deals worth $118.6 billion and Joele Frank, Wilkinson Brimmer Katcher with 35 deals worth $76 billion respectively.
FD took the top slot in terms of volume, working on 102 deals from Q1 to Q3, valued at $50.4 billion. The other two busiest firms were Brunswick and Kekst & Co., the latter of which had 55 deals worth $72.8 billion.
The poor results extend the dry stretch of M&A transactions mergermarket reported earlier this year.
North America enjoyed the scarce good news in the latest release with findings that it enjoyed 49% of total deal value for the first three quarters of 2009, an increase from 38% for the same period in 2008. For the time frame there were 6,256 announced deals valued at $1.05 trillion globally.
